Built for investors and grounded in the latest healthcare data, Qsight Alpha consistently outperforms consensus. It offers unparalleled visibility and precise insights into the sales performance of companies in the MedTech sector through monthly and quarterly tracking of manufacturers.
Guidepoint Qsight Alpha is a powerful tool designed specifically for institutional investors, using the largest datasets available to provide near real-time insights into manufacturer and product-level performance.
Qsight Alpha
With Qsight Alpha, investors can confidently navigate the complexities of the MedTech market, leveraging robust data to identify trends and opportunities ahead of the competition. By staying informed and proactive, investors using Qsight Alpha can capitalize on emerging market trends and position themselves strategically for success.
To use Qsight Alpha, simply access the platform to track monthly and quarterly sales data. This allows you to see beyond standard market consensus with greater accuracy. As an indispensable tool for investors, Qsight Alpha provides precise and predictive revenue visibility to make smarter, data-driven investment decisions in these rapidly evolving industries.
See How Our Accuracy Compares to Consensus!
Nobody is more accurate, across more names. Here’s how we’ve outperformed quarter after quarter all of the way back to 2020.
How Qsight Alpha Can Maximize Investment Potential
Comprehensive MedTech Alpha Tool
Frequently Asked Questions
About Qsight Alpha
Qsight Alpha provides detailed insights and data tracking for companies in the Aesthetics, MedTech and DME sectors.
Qsight Alpha provides unparalleled visibility into the sales performance of MedTech, Aesthetics, and non-acute Medical Device companies.
In the MedTech sector, Qsight Alpha stands out due to its ability to consistently outperform consensus forecasts and its access to comprehensive sales data from over 3,500 U.S. healthcare facilities.
In the Aesthetics sector, it provides access to manufacturer product-level point-of-sale data, capturing medical aesthetics practices’ products and treatments from over 3,500 U.S. locations.
Additionally, access product-level, pharmacy-level, purchase order data, reflecting over $2.3 billion annually in medical equipment, devices, and supplies, purchased by over 5,000 U.S. Durable Medical Equipment (DME) pharmacy locations.
Qsight Alpha uses comprehensive data intelligence derived from an extensive dataset, including purchasing data from over 3,500 healthcare facilities.
This platform offers near real-time insights into manufacturer and product-level performance with a mean absolute percentage error of just 1.68% in its projections since 2021. With weekly updates and detailed monthly data going back to 2010, Qsight Alpha provides investors with precise and predictive revenue visibility.
Delivering More Than Just Data
Request a Demo Today
At Guidepoint Qsight, we empower decisions through unmatched, data-driven insights for the Aesthetics and MedTech industries. Send us your contact information today, and we’ll be in touch to discuss your concerns and overall needs. When it comes to data analytics, we’re the experts you can count on.
The Practitioner Is the New Influencer: How Practitioners Are Reshaping Aesthetic Demand
Not long ago, a celebrity endorsement was the fastest path to aesthetic awareness. Drop a treatment name in a magazine…
Why Sales Planning in Medical Aesthetics Needs a Reset in 2026
Here’s what most sales leaders in medical aesthetics know by now: 2026 isn’t going to look like 2021. Or 2022…
Qsight Social Intelligence: Measuring What Matters in Aesthetic Social Media
In aesthetics, visibility drives growth—but until now, visibility has only been available at the point of sale. Social channels are…
Why Every Aesthetic Product Launch Needs Real-Time Market Insights
Launching a new aesthetics product is one of the highest-stakes moves a brand can make. Success hinges on timing, targeting,…